by Julie Klose, Bound4Life
Hailed as a “research breakthrough,” biotech company Ganogen, Inc. in Redwood City, California has recently harvested kidneys from aborted babies and transplanted them into lab rats. This new development, reported by Live Science, seems eerily right out of a science fiction movie.
While medical advances in organ transplantation have saved lives, how far will we go as a society — both ethically and morally —to further organ donation? Ending a developing life to sustain another begins to resemble playing god.
The goal of Ganogen researchers is to transplant fetal organs into a rat, where the organ could grow to a larger size, and then be transplanted into a human patient in need of a kidney. The process is known as Xenotransplantation. The research study seeks “to grow human organs in animals, to end the human donor shortage,” according to Ganogen founder Eugene Gu.